biomedicina slovenica


angiotensin- : 210

  1. Kotseva Kornelia; Wood David; De Bacquer Dirk; De Backer Guy; Rydén Lars; Jennings Catriona S.; Gyberg Viveca; Amouyel Philippe; Bruthans Jan; Fras Zlatko
    EUROASPIRE IV
    2016
  2. Makuc Jana; Šeruga Maja; Završnik Matej; Cilenšek Ines; Petrovič Danijel
    Angiotensinogen (AGT) gene missense polymorphisms (rs699 and rs4762) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus
    2017
  3. Šeruga Maja; Makuc Jana; Završnik Matej; Cilenšek Ines; Ekart Robert; Petrovič Danijel
    Polymorphism of angiotensin-converting enzyme (rs4340) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus
    2016
  4. Ristić Smiljana; Starčević-Čizmarević Nada; Lavtar Polona; Lovrečić Luca; Perković Olivio; Sepčić Juraj; Šega Saša; Kapović Miljenko; Peterlin Borut
    Angiotensin-converting enzyme insertion/deletion gene polymorphism and interferon-[beta] treatment response in multiple sclerosis patients
    2017
  5. Cafuta Maček Eva; Košnik Mitja; Korošec Peter
    Pogostost, patogeneza in dejavniki tveganja za nastanek angiodema ob prejemanju zaviralcev angiotenzinove konvertaze
    2015
  6. Merlo Sebastjan; Novák J; Tkáčová N; Nikolajević-Starčević Jovana; Šantl-Letonja Marija; Makuc Jana; Cokan Vujkovac Andreja; Letonja Jaušovec Lidija; Bregar Dejan; Zorc Marjeta; Rojko Maksimiljana; Mankoč Ramuš Sara; Kruzliak Peter; Petrovič Danijel
    Association of the ACE rs4646994 and rs4341 polymorphisms with the progression of carotid atherosclerosis in Slovenian patients with type 2 diabetes mellitus
    2015
  7. Rupnik Erik; Kariž Stojan; Iglič Črtomir; Zidarn Mihaela; Košnik Mitja
    Življenje ogrožajoči angioedem po zaviralcu angiotenzinove konvertaze - prikaz dveh primerov
    [Life-threatening angioedema induced by angiotensin-converting enzyme inhibitor - two case reports]
    2015
  8. Ademosun Ayokunle O.; Oboh Ganiyu; Passamonti Sabina; Tramer Federica; Žiberna Lovro; Boligon Aline Augusti; Athayde Margareth Linde
    Phenolics from grapefruit peels inhibit HMG-CoA reductase and angiotensin-I converting enzyme and show antioxidative properties in endothelial EA.Hy 926 cells
    2015
  9. Pal Marjetka; Ferk Polonca
    Interakcije zdravil z zaviralci angiotenzinske konvertaze
    [Drug interactions with angiotensin-converting enzyme inhibitors]
    2012
  10. Janić Miodrag; Lunder Mojca; Šabovič Mišo
    Arterial stiffness and cardiovascular therapy
    2014
  11. Trošt Rupnik Alijana; Pajek Jernej; Guček Andrej; Osredkar Joško; Kovač Damjan; Bren Andrej; Klančič Dimitrij; Saksida Silvana; Rus Igor; Globokar Mateja; Drozg Andrej; Lešnik Marjeta; Plešivčnik Zala; Ekart Robert; Kralj Lopert Simona; Lindič Jelka
    Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients
    2013
  12. Klupka-Sarić Inge; Peterlin Borut; Lovrečić Luca; Sinanović Osman; Vidović Mirjana; Sehanović Aida; Starčević-Čizmarević Nada; Sepčić Juraj; Kapović Miljenko; Ristić Smiljana
    Angiotensin-Converting Enzyme Gene Polymorphism in Patients with Multiple Sclerosis from Bosnia and Herzegovina
    2011
  13. Tomasik Tomasz; Windak Adam; Jozwiak Jacek; Oleszczyk Marek; Seifert Bohumil; Kersnik Janko; Kryj-Radziszewska Elzbieta
    Treatment of hypertension in central and eastern European countries: self-reported practice of primary care physicians
    2012
  14. Trobec Katja; von Haehling Stephan; Anker Stefan D; Lainščak Mitja
    Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia
    2011
  15. Springer Jochen; Lainščak Mitja; Salobir Barbara; Lang Irene M
    Treatment of pulmonary hypertension: bench to bedside
    2011
  16. Bevc Sebastjan
    Aldosteron, zaviralci aldosteronskih receptorjev in kronična ledvična bolezen
    [Aldosterone, aldosterone receptor blockers and chronic kidney disease]
    2011
  17. Camm AJ; Kirchhof P; Lip GY; Zupan I
    Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)
    2010
  18. Štimac Danijela; Polić-Vižintin Marina; Škes Marija; Cattunar Albert; Cerović Robert; Stojanović Dražen
    Utilization of cardiovascular drugs in Zagreb 2001-2005
    2010
  19. Vrtovec Bojan; Poglajen Gregor
    Sodobni načini zdravljenja srčnega popuščanja
    [Modern treatment methods for heart failure]
    2011
  20. Terčelj Marjeta; Salobir Barbara; Zupančič Mirjana; Rylander Ragnar
    Antifungal medication is efficient in the treatment of sarcoidosis
    2011
  21. Bajuk-Studen Katica; Šebeštjen Miran; Pfeifer Marija; Preželj Janez
    Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
    2011
  22. Sinkovič Andreja
    Age-related short-term effect of ramipril on N-terminal pro-brain natriuretic peptide and markers of hemostasis in patients after acute myocardial infarction
    2010
  23. Zupan Igor; Lipar Luka
    Doseganje ciljne srčne frekvence, antiishemična učinkovitost in prenašanje zdravila ivabradin pri bolnikih s stabilno angino pektoris (raziskava OPTIMAL 60)
    [Target heart rate achievement, antiishemic drug efficacy and tolerability of ivabradin in patients with stable angina pectoris (OPTIMAL 60 study)]
    2010
  24. Zajc Milita; Zupan Anton; Bunc Matjaž
    Prizadetost srca pri mišičnih in živčno-mišičnih obolenjih
    [Cardiac involvement in muscle and neuromuscular disorders]
    2010
  25. Sinkovič Andreja
    Bolnik z akutnim miokardnim infarktom - ukrepi ob akutnem dogodku in ukrepanje v bolnišnici
    2010
  26. Šušteršič Miha; Bunc Matjaž
    Nova spoznanja o reninsko-angiotenzinskemu sistemu s poudarkom na (pro)reninu in (pro)reninskem receptorju ter možnostih njune zavore
    [New knowledge of renin-anginotensin-aldosterone system with emphasis on (pro)renin, (pro)renin receptor and possibilities of their blockade]
    2009
  27. Marinšek Martin; Sinkovič Andreja
    A randomized trial comparing the effect of ramipril and losartan in survivors of ST-elevation myocardial infarction
    2009
  28. Lainščak Mitja; Coletta Alison P; Sherwi Nasser; Cleland John G
    Clinical trials update from the Heart failure society of America meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1
    2009
  29. Terčelj Marjeta; Salobir Barbara; Simčič Saša; Wraber Branka; Zupančič Mirjana; Rylander Ragnar
    Chitotriosidase activity in sarcoidosis and some other pulmonary diseases
    2009
  30. Magdič Jožef
    Pleotropni učinki zdravil v preventivi možganskožilnih bolezni
    [Pleiotrophic effects of drugs used for stroke prevention]
    2009
  31. Bombek Mirko
    Ali z izbiro antihipertenzivnega zdravljenja lahko upočasnimo razvoj srčnožilnih bolezni in njihovih posledic?
    [Are we able to slow down the progress of cardiovascular diseases and their fatal events with proper choice of antihipertensive treatment?]
    2009
  32. Bajuk-Studen Katica; Preželj Janez; Kocjan Tomaž; Pfeifer Marija
    Mehanizmi srčno-žilne orgroženosti žensk s sindormom policističnih ovarijev
    [Mechanisms of cardiovascular disease risks in women with polycystic ovary syndrome]
    2009
  33. Šušteršič Miha; Bunc Matjaž
    Nova spoznanja o reninsko-angiotenzisko-aldosteronskem sistemu in nove strategije njegove zavore
    [New knowledge of renin-angiotensin-aldosterone system and new strategies of its blockade]
    2008
  34. von Haehling Stephan; Lainščak Mitja; Springer Jochen; Anker Stefan D
    Cardiac cachexia: a systematic overview
    2008
  35. Poredoš P; Jeiovnik MK
    Does the preventive effect of different drugs depend on location of the atherosclerotic process?
    2008
  36. Dzurenkova D; Hruškovičova H; Kovacs L
    Association between athletic performance and insertion/deletion polymorphism of the gene for angiotensin-converting enzyme
    2002
  37. Petrovič Daniel
    Optimizing cardiac and vascular protection in hypertensive patients with type 2 diabetes
    2008
  38. Salobir B; Medica I; Terčelj M; Kastrin A; Šabovič M; Peterlin B
    Association of angiotensin-converting enzyme/DD genotype with sarcoidosis susceptibility in Slovenian patients
    2007
  39. Osredkar Joško
    Priporočila za uporabo biokemijskih označevalcev pri srčnem popuščanju
    [Recommendations on the use of biochemical markers in heart failure]
    2007
  40. Lainščak Mitja; Cleland John GF; Lenzen Mattie J; Keber Irena; Goode Kevin; Follath Ferenc; Komajda Michel; Swedberg Karl
    Nonpharmacologic measures and drug compliance in patients with heart failure: data from the EuroHeart failure survey
    2007
  41. Virant Mojca
    Vpliv izbranih zaviralcev angiotenzinskega sistema na poškodbe hipoksije-reoksigenacije izolirane prašičje koronarne arterije
    2006
  42. Vrtovec Bojan
    Zdravljenje z zdravili po prebolelem miokardnem infarktu
    2007
  43. Šabovič Mišo
    Pomen zaviralcev angiotenzinske konvertaze pri zdravljenju ishemične bolezni srca
    [The role of ACE inhibitors in the treatment of coronary artery disease]
    2007
  44. Blinc A; Poredoš P
    Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease
    2007
  45. Glavnik N; Petrovič D
    M235T polymorphism of the angiotensinogen gene and insertion/deletion polymorphism of the angiotensin-1 converting enzyme gene in essential arterial hypertension in caucasians
    2007
  46. Lainščak Mitja; Cleland John GF; Lenzen Mattie J; Follath Ferenc; Komajda Michel; Swedberg Karl
    International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart failure survey
    2007
  47. Kolšek Borut
    Neželeni učinki zdravil, ki delujejo na os renin-angiotenzin-aldosteron
    2006
  48. Lovrečić L; Ristić S; Starcević-Čizmarević N; Jazbec ; Sepcić J; Kapović M; Peterlin B
    Angiotensin-converting enzyme I/D gene polymorphism and risk of multiple sclerosis
    2006
  49. Keber Irena
    Pomen antagonistov aldosterona pri zdravljenju kroničnega srčnega popuščanja
    2006
  50. Medica Igor; Kastrin Andrej; Peterlin Borut
    Genetic polymorphisms in vasoactive genes and preeclampsia: a meta-analysis
    2007
  51. Gužič-Salobir Barbara
    Pomen renin-angiotenzinskega sistema pri bolnikih s srčnim popuščanjem
    [The meaning of renin-angiotensin system with patients who have heart failure]
    2006
  52. Keber Irena
    Posodobljene evropske smernice za obravnavo kroničnega srčnega popuščanja - kaj je novega pri farmakološkem zdravljenju
    [The updated European guidelines for the treatment of chronical heart failure - what is new in pharmacological treatment]
    2006
  53. Jug Borut; Šebeštjen Miran; Šabovič Mišo; Keber Irena
    Clopidogrel is associated with a lesser increase in NT-proBNP when compared to aspirin in patients with ischemic heart failure
    2006
  54. Eržen Barbara; Gradišek Primož; Poredoš Pavel; Šabovič Mišo
    Treatment of essential arterial hypertension with enalapril does not result in normalization of endothelial dysfunction of the conduit arteries
    2006
  55. Lipnik-Štangelj Metoda
    Farmakološko zdravljenje arterijske hipertenzije
    2006
  56. Ferjan Mateja; Goličnik Alenka
    Vpliv aktivacije vnetnega odgovora na anemijo pri bolnikih s srčnim popuščanjem
    2005
  57. Klemenc Matjaž
    Zdravljenje bolnika s stabilno angino pektoris z inhibitorji angiotenzinske konvertaze in zaviralci receptorjev za angiotenzin II
    2006
  58. Zorc-Pleskovič Ruda; Teran Nataša; Pleskovič Aleš; Milutinović Aleksandra
    Deletion/deletion genotype of angiotensin-I converting enzyme gene is not associated with coronary artery disease in Caucasians with type 2 diabetes
    2005
  59. Poredoš P
    Prevention of different atherosclerotic diseases: does the effect of preventive measures depend on location of the atherosclerotic process?
    2006
  60. Terzić Rifet; Letonja Mitja; Terzić Ibrahim; Šehić Amela; Merić Muharem; Teran Nataša
    Insertion/deletion polymorphism of angiotensin-converting enzyme gene - risk factor for coronary artery disease in the Tuzla region population (Bosnia and Herzegovina)
    [Insercijski/delecijski polimorfizam u genu angiotenzin konvertirajučeg enzima (ACE) - čimbenik rizika bolesti koronarnih arterija u stanovništvu Tuzlanske regije (Bosna i Herzegovina)]
    2003
  61. Černe Andreja; Kranjec Igor; Peterlin Borut
    Angiotensin-converting enzyme gene polymorphism and acute coronary syndrome
    [Polimorfizmi gena za encim angiotenzinsko konvertazo pri bolnikih z akutnim koronarnim sindromom]
    2005
  62. Bren Andrej; Kandus Aljoša
    Our experience with epoetins in treating renal anemia
    2005
  63. Pajek Jernej; Bučar-Pajek Maja; Grego Katarina; Guček Andrej; Bevc Sebastjan; Ekart Robert; Vujkovac Bojan; Golob-Kosmina Polona; Kandus Aljoša; Bren Andrej F
    Epoetin responsiveness in peritoneal dialysis patients: a multi-center Slovenian study
    2005
  64. Šebeštjen Miran
    Zdravljenje bolnika s srčnim popuščanjem
    2004
  65. Osolnik Katarina
    Interakcije zdravil pri bolnikih z alergijskimi boleznimi in astmo
    2005
  66. Eržen Barbara; Gradišek Primož
    Spremembe žilne stene in sestave krvi pri arterijski hipertenziji
    1995
  67. Vujkovac Bojan; Cokan Andreja; Verovnik Franc; Šabovič Mišo; Benko Davorin
    Effect of angiotensin-converting enzyme inhibitors on proteinuria in patients with fabry disease treated with enzyme replacement therapy
    2005
  68. Kranjec Igor
    Dolgoročna uporaba zaviralcev angiotenzinske konvertaze (ACE) pri bolnikih s koronarno aterosklerozo
    2005
  69. Fras Zlatko; Jug Borut
    Kakovost zgodnje sekundarnopreventivne oskrbe bolnikov po srčnem infarktu v nekaterih slovenskih bolnišnicah
    [Quality of early secondary prevention care after acute myocardial infarction in some of the Slovene hospitals]
    2005
  70. Možina Martin; Jamšek Marija; Šarc Lucija; Grenc Damjan; Brvar Miran
    Zastrupitve
    2005
  71. Cerk Kristina
    Hiperkaliemija pri zdravljenju srčnega popuščanja
    2004
  72. Petrovič Daniel; Peterlin Borut
    Genetic markers of restenosis after coronary angioplasty and after stent implantation
    2005
  73. Marčun-Varda N; Peterlin B; Umek-Bradač S; Gregorič A
    Carotid artery intima-media thickness and angiotensin-converting enzyme gene polymorphism in the offspring of parents with premature stroke
    2005
  74. Vašku V; Vašku JA; Pavkova-Goldbergova M; Vašku A
    Association of variants in angiotensin-converting enzyme and endothelin-1 genes with phototherapy in cutaneous T-cell lymphoma
    2004
  75. Dobovišek Jurij
    Zdravljenje hipertenzijske hipertrofije levega prekata
    2004
  76. Kolšek Borut; Klemenc Matjaž
    Nadzor hipertenzije pri srčni odpovedi
    2004
  77. Kolšek Borut
    Nadzor hipertenzije pri ishemični bolezni srca
    2004
  78. Žemva Aleš
    Pregled antihipertenzijskih zdravil
    2004
  79. Dobovišek Jurij
    Terapevtski pristop k hipertenziji
    2004
  80. Lainščak Mitja
    Implementation of guidelines for management of heart failure in heart failure clinic: effects beyond pharmacological treatment
    2004
  81. Accetto Rok
    Izbira antihipertenzijskega zdravila
    2004
  82. Kržišnik-Zorman Simona
    Koronarna bolezen pri starostnikih - zdravljenje bolnikov z akutnim miokardnim infarktom
    [Coronary disease in elderly patients - management of patients with acute myocardial infarction]
    2004
  83. Žemva Aleš
    Klinične in farmakološke značilnosti zdravil za zniževanje krvnega tlaka
    2004
  84. Keber Irena
    Srčno popuščanje pri starih
    2004
  85. Keber Irena; Jug Borut; Šebeštjen Miran
    Dispneja in srčno popuščanje
    2004
  86. Šabovič Mišo
    Zmanjšanje oksidativnega stresa v arterijski steni: (nova) možnost za preprečevanje in zdravljenje ateroskleroze
    2004
  87. Dobovišek Jurij
    Zdravljenje arterijske hipertenzije pri bolnikih z ledvično odpovedjo
    2004
  88. Ružič-Medvešček Nadja
    Arterijska hipertenzija in srčno popuščanje
    2004
  89. Vodopivec-Jamšek Vlasta
    Vodenje bolnika po srčnem infarktu pri posebnih skupinah bolnikov
    2004
  90. Dobovišek Jurij
    Izbira zdravila in najbolj racionalne kombinacije zdravil za zdravljenje arterijske hipertenzije
    2004
  91. Vodopivec-Jamšek Vlasta
    Prikaz smernic za obravnavo bolnikov po akutnem srčnem infarktu v družinski medicini
    [Guidelines for management of patients following myocardial infarction in family medicine]
    2004
  92. Šabovič Mišo
    Novi podatki o vplivu ACE-inhibitorjev na upočasnitev ateroskleroze
    [New data on the effect of ACE inhibitors on retarding atherosclerosis]
    2004
  93. Alderman Michael H
    Študija INVEST: ameriški komentar
    [The return on INVEST]
    2004
  94. McGill Henry C; McMahan C Alex
    Pričeti prej, da bi preprečili bolezen srca: ameriški komentar
    [Starting earlier to prevent heart disease]
    2004
  95. Pepine Carl J; Handberg Eileen M; Cooper-DeHoff Rhonda M; Marks Ronald G; Kowey Peter; Messerly Franz H; Manzia Giuseppe; Cangiano Jose L; Garcia-Barreto David; Keltai Matyas
    Zdravljenje hipertenzije s kalcijevimi antagonisti v primerjavi z nekalcijevimi antagonisti pri bolnikih s koronarno boleznijo: študija International verapamil trandolapril (INVEST): randomizirana nadzorovana raziskava
    [A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International verapamil - trandolapril study (INVEST): a randomized controlled trial]
    2004
  96. Modrijančič Mojca; Drinovec Jože; Mrhar Aleš
    Some pharmacoeconomic aspects of congestive heart failure in Slovenia
    [Nekateri farmakoekonomski vidiki srčnega popuščanja v Sloveniji]
    2004
  97. Osolnik Katarina
    Interakcije zdravil pri bolnikih z alergijskimi boleznimi in astmo
    2004
  98. Kenda Miran F; Šebeštjen Miran
    Pharmacological approach for the prevention of sudden death in patients with congestive heart failure
    2004
  99. Kenda Miran F
    Nenadna srčna smrt - obseg problema
    2003
  100. Petrovič Daniel; Bregar Dejan; Gužič-Salobir Barbara; Škof Erik; Špan Matjaž; Terzić Rifet; Globočnik-Petrovič Mojca; Keber Irena; Letonja Mitja; Zorc Marjeta; Podbregar M; Peterlin Borut
    Sex difference in the effect of ACE-DD genotype on the risk of premature myocardial infarction
    2004

1 101 201  


Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko